Harve Wilson - Concepedia

Author

Harve Wilson

Eli Lilly (United States)

Also Known As

H C Wilson, H. Christopher Wilson, HARVE C. WILSON, Harve C Wilson, Harve C. Wilson, Harve Wilson

Publications

409

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)

About

Harve Wilson is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	240
2	Anesthesia	2	2	79
3	Health Sciences	1	1	15
4	Natural Sciences	1	1	56
5	Public Health	1	1	17

Harve Wilson

Publications

382

Citations

H-Index

Page 1

	Year	Citations
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-spiro[cycloalkane-1,3'-[3H]indol]-2'(1'H)-ones David W. Robertson, Joseph H. Krushinski, G. Don Pollock, Journal of Medicinal Chemistry	1987	80
Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine David W. Robertson, E. E. Beedle, Joseph H. Krushinski, Journal of Medicinal Chemistry Combinatorial ChemistryHeterocyclicBiochemistrySeveral NoncatecholamineMedicine	1985	73
Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinone David W. Robertson, E. E. Beedle, J. K. SWARTZENDRUBER, Journal of Medicinal Chemistry Bipyridine CardiotonicsCardiac MuscleHeart RateHeart FailureCardiomyopathy	1986	66
Dihydropyridazinone cardiotonics. The discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H-indol-2-one David W. Robertson, Joseph H. Krushinski, E. E. Beedle, Journal of Medicinal Chemistry Medicinal ChemistryBioorganic ChemistryPharmacological StudyBiochemistryAntiparasitic Agent	1986	56
Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis. Charles V. Jackson, V G Crowe, Judit Frank, Journal of Pharmacology and Experimental Therapeutics	1992	28
Reversible Tripeptide Thrombin Inhibitors as Adjunctive Agents to Coronary Thrombolysis Charles V. Jackson, Harve Wilson, V. Gail Growe, Journal of Cardiovascular Pharmacology	1993	24
The effects of various nutritional supplements on the growth, migration and differentiation ofxenopus laevis neural crest cells in vitro Harve Wilson, Nadine C. Milos In Vitro Cellular & Developmental Biology - Plant Animal PhysiologyDevelopmental BiologyVarious Nutritional SupplementsPhysiologyCell Culture	1987	17
Protamine-Induced Hypocalcemia C. Conrad Johnston, Edward L. Grinnan, Harve Wilson, Endocrinology Animal PhysiologyBone ResorptionMedicinePhysiologyWhereas Protamine	1970	15
Pharmacology of LY195115, a Potent, Orally Active Cardiotonic with a Long Duration of Action J. Scott Hayes, G. Donald Pollock, Harve Wilson, Journal of Cardiovascular Pharmacology Cardiac MuscleCardiovascular PharmacologyPharmacotherapyNeuromuscular BlockadeLong Duration	1987	13
LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis. Marlene L. Cohen, David W. Robertson, William E. Bloomquist, Journal of Pharmacology and Experimental Therapeutics	1992	10

Page 1